| Clinical data | |
|---|---|
| Trade names | Tonquil, Vesitan |
| Other names | Chlorphencyclan |
| Routes of administration | Oral |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C18H28ClNO |
| Molar mass | 309.88 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Clofenciclan (also known aschlorphencyclan; trade namesTonquil andVesitan) is adopamine-releasing agent developed by Boehringer & Soehne in the 1950s.[1][2] It proved unpopular as a treatment because of its pronouncedstimulant activity.[3]
Sila analogues of clorphencyclane were developed.[4]
Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it. |